Biotech Values

[DewDiligence]

ENOB +239%(!)/PM on pre-IND FDA meeting re stemcell transplant for HIV:

https://www.globenewswire.com/news-release/2020/06/08/2044839/0/en/Enochian-BioSciences-Announces-Its-Successful-Completion-of-FDA-INTERACT-Meeting-for-a-Potential-Cure-for-HIV.html

ENOB, an 8-person outfit in Los Angeles, went public in Feb 2018 via a reverse merger with DDRT (https://www.prnewswire.com/news-releases/dandrit-biotech-announces-completion-of-the-acquisition-of-enochian-300600864.html ).